Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479502![]() (ML300-based SC inhibitor 41) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | Purchase PC cid PC sid UniChem | PubMed | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479482![]() (ML300-based SC inhibitor 21) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479502![]() (ML300-based SC inhibitor 41) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | Purchase PC cid PC sid UniChem | PubMed | n/a | n/a | 68 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479492![]() (ML300-based SC inhibitor 31) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479480![]() (ML300-based SC inhibitor 19) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479480![]() (ML300-based SC inhibitor 19) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479493![]() (ML300-based SC inhibitor 32) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 111 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479492![]() (ML300-based SC inhibitor 31) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 119 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479482![]() (ML300-based SC inhibitor 21) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479501![]() (ML300-based SC inhibitor 40) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 171 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479493![]() (ML300-based SC inhibitor 32) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 176 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479499![]() (ML300-based SC inhibitor 38) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 197 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479498![]() (ML300-based SC inhibitor 37) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 206 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479499![]() (ML300-based SC inhibitor 38) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 208 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479501![]() (ML300-based SC inhibitor 40) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 214 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479489![]() (ML300-based SC inhibitor 28) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479497![]() (ML300-based SC inhibitor 36) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479494![]() (ML300-based SC inhibitor 33) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 312 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479498![]() (ML300-based SC inhibitor 37) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 328 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479500![]() (ML300-based SC inhibitor 39) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 333 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479497![]() (ML300-based SC inhibitor 36) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 334 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479500![]() (ML300-based SC inhibitor 39) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 336 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479495![]() (ML300-based SC inhibitor 34) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 370 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479471![]() (ML300-based SC inhibitor 10) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 380 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479489![]() (ML300-based SC inhibitor 28) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 390 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479494![]() (ML300-based SC inhibitor 33) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 418 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479471![]() (ML300-based SC inhibitor 10) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 440 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479495![]() (ML300-based SC inhibitor 34) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 540 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479496![]() (ML300-based SC inhibitor 35) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 657 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479496![]() (ML300-based SC inhibitor 35) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 746 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479485![]() (ML300-based SC inhibitor 24) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 780 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479478![]() (ML300-based SC inhibitor 17) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 780 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479485![]() (ML300-based SC inhibitor 24) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 830 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479503![]() (ML300-based SC inhibitor 42) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 864 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479475![]() (ML300-based SC inhibitor 14) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479478![]() (ML300-based SC inhibitor 17) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 920 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM429464![]() (ML300-based SC inhibitor 8 | acs.jmedchem.1c00409_...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 930 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM429464![]() (ML300-based SC inhibitor 8 | acs.jmedchem.1c00409_...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 950 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479486![]() (ML300-based SC inhibitor 25) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479488![]() (ML300-based SC inhibitor 27) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479486![]() (ML300-based SC inhibitor 25) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.16E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479503![]() (ML300-based SC inhibitor 42) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479473![]() (ML300-based SC inhibitor 12) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479475![]() (ML300-based SC inhibitor 14) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479476![]() (ML300-based SC inhibitor 15 | acs.jmedchem.1c00409...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.57E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479488![]() (ML300-based SC inhibitor 27) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.59E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479473![]() (ML300-based SC inhibitor 12) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.61E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479476![]() (ML300-based SC inhibitor 15 | acs.jmedchem.1c00409...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 2.09E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479484![]() (ML300-based SC inhibitor 23) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 2.44E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479484![]() (ML300-based SC inhibitor 23) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 2.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479504![]() (ML300-based SC inhibitor 43) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 2.72E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479477![]() (ML300-based SC inhibitor 16 | acs.jmedchem.1c00409...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 3.09E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479504![]() (ML300-based SC inhibitor 43) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 3.44E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479483![]() (ML300-based SC inhibitor 22) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 4.21E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479369![]() (ALP-POS-c59291d4-3 | ML300-based SC inhibitor 1 | ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 4.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479483![]() (ML300-based SC inhibitor 22) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 4.62E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479490![]() (ML300-based SC inhibitor 29) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 4.87E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479369![]() (ALP-POS-c59291d4-3 | ML300-based SC inhibitor 1 | ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | 4.99E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479477![]() (ML300-based SC inhibitor 16 | acs.jmedchem.1c00409...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 5.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479474![]() (ML300-based SC inhibitor 13) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 7.98E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479490![]() (ML300-based SC inhibitor 29) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 8.53E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479474![]() (ML300-based SC inhibitor 13) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 8.77E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479481![]() (ML300-based SC inhibitor 20) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 9.55E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479481![]() (ML300-based SC inhibitor 20) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.13E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479472![]() (ML300-based SC inhibitor 11) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.59E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479472![]() (ML300-based SC inhibitor 11) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.66E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM429465![]() (ALP-POS-c59291d4-1 | ML300-based SC inhibitor 7 | ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.68E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479470![]() (ML300-based SC inhibitor 9) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.89E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479470![]() (ML300-based SC inhibitor 9) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.97E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479479![]() (ML300-based SC inhibitor 18) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 2.04E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479487![]() (ML300-based SC inhibitor 26) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3C-like proteinase (3CL-PRO) (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM479479![]() (ML300-based SC inhibitor 18) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 2.28E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479487![]() (ML300-based SC inhibitor 26) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 2.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM429465![]() (ALP-POS-c59291d4-1 | ML300-based SC inhibitor 7 | ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | 3.12E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description The protease activity and subsequent 10-point IC50 curves were spectroscopically determined using a scaled down, end point assay adapted from a previ... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479480![]() (ML300-based SC inhibitor 19) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | n/a | n/a | 5.76E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479497![]() (ML300-based SC inhibitor 36) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 3.31E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM429464![]() (ML300-based SC inhibitor 8 | acs.jmedchem.1c00409_...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | n/a | n/a | 1.21E+4 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479499![]() (ML300-based SC inhibitor 38) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 2.01E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479496![]() (ML300-based SC inhibitor 35) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | n/a | n/a | 8.77E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479489![]() (ML300-based SC inhibitor 28) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 1.11E+4 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479489![]() (ML300-based SC inhibitor 28) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 7.61E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479501![]() (ML300-based SC inhibitor 40) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 1.91E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479369![]() (ALP-POS-c59291d4-3 | ML300-based SC inhibitor 1 | ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | n/a | n/a | 2.82E+4 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479502![]() (ML300-based SC inhibitor 41) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | Purchase PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 500 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479500![]() (ML300-based SC inhibitor 39) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 4.65E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479500![]() (ML300-based SC inhibitor 39) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 3.81E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479482![]() (ML300-based SC inhibitor 21) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | n/a | n/a | 1.75E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479369![]() (ALP-POS-c59291d4-3 | ML300-based SC inhibitor 1 | ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | n/a | n/a | 1.99E+4 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479499![]() (ML300-based SC inhibitor 38) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 2.30E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479497![]() (ML300-based SC inhibitor 36) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 1.98E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479496![]() (ML300-based SC inhibitor 35) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | n/a | n/a | 1.67E+4 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479480![]() (ML300-based SC inhibitor 19) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | n/a | n/a | 7.63E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM429464![]() (ML300-based SC inhibitor 8 | acs.jmedchem.1c00409_...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | n/a | n/a | 1.46E+4 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479502![]() (ML300-based SC inhibitor 41) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | Purchase PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 560 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479498![]() (ML300-based SC inhibitor 37) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 3.24E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479498![]() (ML300-based SC inhibitor 37) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 2.93E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479482![]() (ML300-based SC inhibitor 21) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid PDB UniChem | PubMed | n/a | n/a | n/a | n/a | 1.74E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Briefly, Vero E6 ACE2 cells were cultured in 96-well flat-bottom plates at a density of 2 × 104 cells per well. Following infection of the cells with... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (2019-nCoV) | BDBM479501![]() (ML300-based SC inhibitor 40) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank GoogleScholar | PC cid PC sid UniChem | PubMed | n/a | n/a | n/a | n/a | 3.39E+3 | n/a | n/a | n/a | n/a |
Cleveland Clinic | Assay Description Confluent monolayers of Vero E6 ACE2 cells in 12-well plates were washed once with DMEM and infected with approximately 50 plaque forming units (PFUs... | J Med Chem 64: (2021) | |||||||||||
More data for this Ligand-Target Pair |